1997
DOI: 10.1002/mrm.1910380411
|View full text |Cite
|
Sign up to set email alerts
|

Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis

Abstract: Proton (1H) magnetic resonance (MR) spectra of ex vivo biopsy samples of ovarian cancers provided biochemical information that was used to discriminate cancer from normal ovarian tissue. Possible differences present in intrinsically resistant tumors or changes in biochemistry after the induction of resistance were identified. Using multivariate techniques, in particular linear discriminant analysis (LDA), ovarian cancer was distinguished from normal ovarian tissue with a sensitivity of 100%, a specificity of 9… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
30
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(31 citation statements)
references
References 17 publications
1
30
0
Order By: Relevance
“…Motivations for application of the FPT were provided by the quite extensive data using in vitro MRS [30,54,[62][63][64][65][66][67][68][69]. Further, as thoroughly reviewed in Ref.…”
Section: In Vivo Encoded Mrs Time Signals Using Conventional Fourier-mentioning
confidence: 99%
“…Motivations for application of the FPT were provided by the quite extensive data using in vitro MRS [30,54,[62][63][64][65][66][67][68][69]. Further, as thoroughly reviewed in Ref.…”
Section: In Vivo Encoded Mrs Time Signals Using Conventional Fourier-mentioning
confidence: 99%
“…These deficiencies in the method will introduce some extra variance into the data. They may be overcome by procedures not presently available in our laboratory (use of magnitude spectra and automated integration [22]). Other whole-organism fingerprinting techniques are reported to require strict control of growth media and repeated standardization with control cultures (11,12).…”
Section: Discussionmentioning
confidence: 99%
“…Pattern recognition techniques, which detect gross spectral characteristics associated with a priori-defined classes (such as pathological conditions), have been successfully applied to MRS of both tissues and body fluids. Accurate and reliable classifiers based on multivariate analyses of 1 H MR spectroscopic data have been developed and validated for objective diagnosis of thyroid (21), ovarian (22), prostate (9), breast (13), and brain (20) tumors. In some pathologies, MRS is able to detect malignancy before morphological manifestations are visible by light microscopy (17).…”
mentioning
confidence: 99%
“…It cannot reliably separate out the noise that corrupts the recorded MRS time signal, such that poor SNR is a major problem when using clinical MR scanners. Yet, there are many MR-observable compounds that characterize malignant versus benign ovarian lesions using in vitro MRS [50,[56][57][58][59][60][61][62].…”
Section: In Vivo Magnetic Resonance Spectroscopy Of the Ovary: The Prmentioning
confidence: 99%
“…In an investigation of 19 normal or benign ovarian samples, 3 with BL pathology and 37 ovarian cancers [57], amplitude ratios of peaks at 0.9 ppm (Lip methyl), 1.3 ppm (Lip methylene), 1.7 ppm (Lys and polyamines) and 3.2 ppm (Cho), distinguished normal or benign samples from BL and malignant ovarian samples with a sensitivity of 95 % and specificity of 86 %.…”
Section: In Vitro Mrs Findings From the Ovarymentioning
confidence: 99%